Ghost Tree Capital as of June 30, 2018
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 45 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 8.7 | $30M | 1.3M | 23.67 | |
| Mirati Therapeutics | 7.3 | $25M | 500k | 49.30 | |
| Sarepta Therapeutics (SRPT) | 6.8 | $23M | 175k | 132.18 | |
| Ptc Therapeutics I (PTCT) | 6.7 | $23M | 675k | 33.73 | |
| Alnylam Pharmaceuticals (ALNY) | 6.1 | $21M | 210k | 98.49 | |
| Bluebird Bio (BLUE) | 4.9 | $17M | 105k | 156.95 | |
| Argenx Se (ARGX) | 3.7 | $12M | 150k | 82.86 | |
| Ascendis Pharma A S (ASND) | 3.4 | $12M | 175k | 66.52 | |
| Global Blood Therapeutics In | 3.2 | $11M | 242k | 45.20 | |
| Mersana Therapeutics (MRSN) | 3.2 | $11M | 600k | 17.86 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.8 | $9.5M | 700k | 13.60 | |
| Assembly Biosciences | 2.7 | $9.2M | 235k | 39.21 | |
| Exelixis (EXEL) | 2.5 | $8.6M | 400k | 21.52 | |
| ACADIA Pharmaceuticals (ACAD) | 2.4 | $8.2M | 535k | 15.27 | |
| Dicerna Pharmaceuticals | 2.4 | $8.1M | 660k | 12.25 | |
| Adamas Pharmaceuticals | 2.2 | $7.6M | 295k | 25.83 | |
| Kadmon Hldgs | 2.2 | $7.6M | 1.9M | 3.99 | |
| Endocyte | 2.0 | $6.9M | 500k | 13.80 | |
| Rocket Pharmaceuticals (RCKT) | 2.0 | $6.9M | 350k | 19.63 | |
| Madrigal Pharmaceuticals (MDGL) | 1.9 | $6.6M | 24k | 279.70 | |
| Avrobio Ord (AVRO) | 1.9 | $6.6M | 230k | 28.56 | |
| Glycomimetics (GLYC) | 1.9 | $6.5M | 400k | 16.13 | |
| Viewray (VRAYQ) | 1.8 | $6.2M | 900k | 6.92 | |
| Obseva Sa | 1.8 | $6.1M | 400k | 15.14 | |
| Tricida | 1.6 | $5.6M | 186k | 29.90 | |
| Audentes Therapeutics | 1.4 | $4.8M | 125k | 38.21 | |
| Iovance Biotherapeutics (IOVA) | 1.4 | $4.6M | 360k | 12.80 | |
| BioDelivery Sciences International | 1.2 | $4.2M | 1.4M | 2.95 | |
| Kura Oncology (KURA) | 1.2 | $4.2M | 230k | 18.20 | |
| Catalyst Biosciences | 1.2 | $4.1M | 355k | 11.67 | |
| Apellis Pharmaceuticals (APLS) | 1.2 | $4.1M | 185k | 22.00 | |
| Neos Therapeutics | 1.1 | $3.8M | 600k | 6.25 | |
| Lannett Company | 1.0 | $3.4M | 252k | 13.60 | |
| Genocea Biosciences | 0.9 | $3.0M | 3.5M | 0.86 | |
| Flamel Technologies Sa (AVDL) | 0.8 | $2.8M | 450k | 6.13 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $1.1M | 16k | 71.02 | |
| Zafgen | 0.3 | $1.0M | 102k | 10.23 | |
| Acorda Therapeutics | 0.3 | $947k | 33k | 28.70 | |
| Puma Biotechnology (PBYI) | 0.2 | $828k | 14k | 59.14 | |
| Edge Therapeutics | 0.2 | $773k | 751k | 1.03 | |
| Motus Gi Hldgs Incorporated | 0.2 | $719k | 100k | 7.19 | |
| Tg Therapeutics (TGTX) | 0.2 | $684k | 52k | 13.15 | |
| Spectrum Pharmaceuticals | 0.2 | $608k | 29k | 20.97 | |
| SPDR S&P Biotech (XBI) | 0.1 | $525k | 5.0k | 105.00 | |
| Biohaven Pharmaceutical Holding | 0.0 | $122k | 2.0k | 61.00 |
